|
Diabetes, Vol 44, Issue 6 682-688, Copyright © 1995 by American Diabetes Association
Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle
JO Carey, JL Azevedo, PG Morris, WJ Pories and GL Dohm
Department of Biochemistry, East Carolina University, School of Medicine, Greenville, NC 27585, USA.
In response to insulin, several proteins are phosphorylated on tyrosine and
on serine/threonine residues. Decreased phosphorylation of signaling
peptides by a defective insulin receptor kinase may be a cause of insulin
resistance. Accordingly, inhibition of the appropriate phosphatases might
increase the phosphorylation state of these signaling peptides and thereby
elicit increased glucose transport. The purpose of this study was to
examine the effect of the serine/threonine phosphatase inhibitor okadaic
acid and the tyrosine phosphatase inhibitors phenylarsine oxide and
vanadate on 2-deoxyglucose transport in insulin-resistant human skeletal
muscle. All three phosphatase inhibitors stimulated 2-deoxyglucose
transport in insulin-resistant skeletal muscle. These data suggest that
these compounds have bypassed a defect in at least one of the signaling
pathways leading to glucose transport. Furthermore, maximal transport rates
induced by the simultaneous presence of insulin and phosphatase inhibitor
in insulin-resistant muscle were equal to insulin-stimulated rates in lean
control subjects. However, both vanadate alone and vanadate plus insulin
stimulated 2-deoxyglucose transport significantly more in insulin-sensitive
tissue than in insulin-resistant tissue. These results demonstrate that
although vanadate is able to stimulate glucose transport in
insulin-resistant muscle, it is not able to normalize transport to the same
rate achieved in insulin-sensitive muscle.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Asante-Appiah and B. P. Kennedy
Protein tyrosine phosphatases: the quest for negative regulators of insulin action
Am J Physiol Endocrinol Metab,
April 1, 2003;
284(4):
E663 - E670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Barbagallo, L. J. Dominguez, and L. M. Resnick
Insulin-Mimetic Action of Vanadate: Role of Intracellular Magnesium
Hypertension,
September 1, 2001;
38(3):
701 - 704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Korge, J. I. Goldhaber, and J. N. Weiss
Phenylarsine oxide induces mitochondrial permeability transition, hypercontracture, and cardiac cell death
Am J Physiol Heart Circ Physiol,
May 1, 2001;
280(5):
H2203 - H2213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Cusi, S. Cukier, R. A. DeFronzo, M. Torres, F. M. Puchulu, and J. C. P. Redondo
Vanadyl Sulfate Improves Hepatic and Muscle Insulin Sensitivity in Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
March 1, 2001;
86(3):
1410 - 1417.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. N. Cortright, J. L. Azevedo Jr., Q. Zhou, M. Sinha, W. J. Pories, S. I. Itani, and G. L. Dohm
Protein kinase C modulates insulin action in human skeletal muscle
Am J Physiol Endocrinol Metab,
March 1, 2000;
278(3):
E553 - E562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Shepherd and B. B. Kahn
Glucose Transporters and Insulin Action -- Implications for Insulin Resistance and Diabetes Mellitus
N. Engl. J. Med.,
July 22, 1999;
341(4):
248 - 257.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Hubbard, M. Mohammadi, and J. Schlessinger
Autoregulatory Mechanisms in Protein-tyrosine Kinases
J. Biol. Chem.,
May 15, 1998;
273(20):
11987 - 11990.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Torrance, S. J. Usala, J. E. Pessin, and G. L. Dohm
Characterization of a Low Affinity Thyroid Hormone Receptor Binding Site within the Rat GLUT4 Gene Promoter
Endocrinology,
March 1, 1997;
138(3):
1215 - 1223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Rondinone and U. Smith
Okadaic Acid Exerts a Full Insulin-like Effect on Glucose Transport and Glucose Transporter 4Translocation in Human Adipocytes. EVIDENCE FOR A PHOSPHATIDYLINOSITOL 3-KINASE-INDEPENDENT PATHWAY
J. Biol. Chem.,
July 26, 1996;
271(30):
18148 - 18153.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|